Stonebridge Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-43,379
| Closed | -$182K | – | 146 |
|
|
2018
Q3 | $182K | Buy |
43,379
+17,038
| +65% | +$71.5K | 0.06% | 125 |
|
|
2018
Q2 | $106K | Buy |
26,341
+381
| +1% | +$1.53K | 0.04% | 128 |
|
|
2018
Q1 | $177K | Buy |
25,960
+2,383
| +10% | +$16.2K | 0.06% | 122 |
|
|
2017
Q4 | $200K | Buy |
+23,577
| New | +$200K | 0.07% | 126 |
|
|
2017
Q3 | – | Sell |
-10,257
| Closed | -$100K | – | 145 |
|
|
2017
Q2 | $100K | Buy |
10,257
+5,615
| +121% | +$54.7K | 0.04% | 134 |
|
|
2017
Q1 | $112K | Buy |
+4,642
| New | +$112K | 0.05% | 120 |
|